Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy

OBJECTIVE: We hypothesized that intranasal insulin (I-I) delivery targets the nervous system while avoiding potential adverse systemic effects when compared with subcutaneous insulin (S-I) for experimental streptozotocin-induced diabetic peripheral neuropathy (DPN). RESEARCH DESIGN AND METHODS: I-I...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Francis, George, Martinez, Jose, Liu, Wei, Nguyen, Thuhien, Ayer, Amit, Fine, Jared, Zochodne, Douglas, Hanson, Leah R., Frey, William H., Toth, Cory
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Diabetes Association 2009
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2661595/
https://ncbi.nlm.nih.gov/pubmed/19136650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db08-1287
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak